Immunology Meets Bioengineering: Improving the Effectiveness of Glioblastoma Immunotherapy

SIMPLE SUMMARY: Glioblastoma (GBM) is the main malignant brain tumor in adults. It has a poor survival rate and a short disease-free life in spite of all available treatments. The science of cancer immunotherapy is constantly adapting to address the particular needs and problems of a wide range of c...

Descripción completa

Detalles Bibliográficos
Autores principales: Fekrirad, Zahra, Barzegar Behrooz, Amir, Ghaemi, Shokoofeh, Khosrojerdi, Arezou, Zarepour, Atefeh, Zarrabi, Ali, Arefian, Ehsan, Ghavami, Saeid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367505/
https://www.ncbi.nlm.nih.gov/pubmed/35954362
http://dx.doi.org/10.3390/cancers14153698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367505/
https://www.ncbi.nlm.nih.gov/pubmed/35954362
http://dx.doi.org/10.3390/cancers14153698

Ejemplares similares